Related Articles
Aberrant methylation of LINE-1, SLIT2, MAL and IGFBP7 in non-small cell lung cancer
Aberrant microRNA-137 promoter methylation is associated with lymph node metastasis and poor clinical outcomes in non-small cell lung cancer
Hypermethylation of MDFI promoter with NSCLC is specific for females, non‑smokers and people younger than 65
FHIT promoter methylation status, low protein and high mRNA levels in patients with non-small cell lung cancer
Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancers